Diminished survival in patients with inner versus outer quadrant breast cancers

Journal of Clinical Oncology

Volumn 21, Issue 3, 2003, Pages 467-472

  Gaffney, David K ^a   Tsodikov, Alexander ^a   Wiggins, Charles L ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ARTICLE; AXILLARY LYMPH NODE; BODY REGIONS; BREAST CANCER; CANCER GRADING; CANCER INVASION; CANCER LOCALIZATION; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME; ADULT; AGED; ANTHROPOMETRY; BREAST; BREAST TUMOR; CANCER REGISTRY; COHORT ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; HISTOLOGY; LYMPH NODE METASTASIS; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; RISK FACTOR; SEGMENTAL MASTECTOMY;

ADULT; AGED; ANTHROPOMETRY; BREAST; BREAST NEOPLASMS; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MASTECTOMY; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM STAGING; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; RISK FACTORS; SEER PROGRAM;

EID: 0037318141     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2003.12.047     Document Type: Article

References (32)

1. Zucali R, Mariani L, Marubini E, et al: Early breast cancer: Evaluation of the prognostic role of the site of the primary tumor. J Clin Oncol 16:1363-1366, 1998
2. Lohrisch C, Jackson J, Jones A, et al: Relationship between tumor location and relapse in 6,781 women with early invasive breast cancer. J Clin Oncol 18:2828-2835, 2000
3. Hammer J, Track C, Seewald DH: Breast cancer: The medial tumor location-An unfavorable disease! Results from 644 patients (1984-1995). Radiother Oncol 58:38, 2001 (suppl 1)
4. van der Ent FW, Kengen RA, van der Pol HA, et al: Halsted revisited: Internal mammary sentinel lymph node biopsy in breast cancer. Ann Surg 234:79-84, 2001
5. Krag DN, Harlow S, Weaver D, et al: Radiolabelled sentinel node biopsy: Collaborative trial with the National Cancer Institute. World J Surg 25:823-828, 2001
6. Uren RF, Howman-Giles R, Renwick SB, et al: Lymphatic mapping of the breast: Locating the sentinel lymph node. World J Surg 25:789-793, 2001
7. Handley R: Natural history of breast cancer, in Harris J, Lippman ME, Morrow M, et al (eds): Diseases of the Breast. Philadelphia, PA, WB Saunders, 1996, p 364
8. Urban J: Is there a rationale for an extended radical procedure? Int J Radiat Oncol Biol Phys 2:985-988, 1977
9. Lacour J, Le M, Caceres E, et al: Radical mastectomy versus radical mastectomy plus internal mammary dissection. Cancer 51:1941-1943, 1983
10. Veronesi U, Valagussa P: Inefficacy of internal mammary node dissection in breast cancer surgery. Cancer 47:170-175, 1981
11. Morrow M, Foster RS: Staging of breast cancer: A new rationale for internal mammary node biopsy. Arch Surg 116:748-751, 1981
12. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:456-481, 1958
13. Host H, Brenvold IO, Loeb M: Post-operative radiotherapy in operable breast cancer: Long term results from the Oslo study. Int J Radiat Oncol Biol Phys 12:727-732, 1986
14. Wallgren A, Arner O, Bergstrom J, et al: Radiation therapy in operable breast cancer: Results from the Stockholm trial on adjuvant therapy. Int J Radiat Oncol Biol Phys 12:533-537, 1986
15. Arriagada R, Le MG, Mouriesse H, et al: Long-term effective internal mammary chain treatment: Results of a multivaried analysis of 1,195 patients with operable breast cancer and positive axillary nodes. Radiother Oncol 11:213-222, 1988
16. Overgaard M, Hansen PS, Overgaard J, et al: Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 337:949-955, 1997
17. Overgaard M, Jensen M-B, Overgaard J, et al: Postoperative radiotherapy in high-risk postmenopausal women with breast cancer given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 353:1641-1648, 1999
18. Ragaz J, Stewart MJ, Le N, et al: Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 337:956-962, 1997
19. Early Breast Cancer Trialists' Collaborative Group: Polychemotherapy for early breast cancer. An overview of the randomised trials. Lancet 352:930-942, 1998
20. Early Breast Cancer Trialists' Collaborative Group: Tamoxifen for early breast cancer. An overview of the randomised trials. Lancet 351:1451-1467, 1998
21. Early Breast Cancer Trialists' Collaborative Group: Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer. An overview of the randomised trials. Lancet 355:1757-1770, 2000
22. Recht A, Pierce SM, Abner A, et al: Regional nodal failure after conservative surgery and radiotherapy for early stage breast cancer. J Clin Oncol 9:988-996, 1991
23. Proulx GM, Lee RJ, Stomper PC: Internal mammary lymph node inclusion in standard tangent breast fields: Effects of body habitus. Breast J 7:111-116, 2001
24. Bickell NA, Chassin MR: Determining the quality of breast cancer care: Do tumor registries measure up? Ann Intern Med 132:705-710, 2000
25. Malin JL, Kahn KL, Adams J, et al: Validity of cancer registry data for measuring the quality of breast cancer care. J Natl Cancer Inst 94:835-844, 2002
26. Percy C, Stanek E, Gloeckler L: Accuracy of cancer death certificates and its effect on cancer mortality statistics. Am J Public Health 71:242-250, 1981
27. Du X, Freeman JL, Goodwin JS: Information on radiation treatment in patients with breast cancer: The advantages of the linked Medicare and SEER data. J Clin Epidemiol 52:463-470, 1999
28. Freedman GM, Fowble BL, Nicolaou N, et al: Should internal mammary lymph nodes in breast cancer be a target for the radiation oncologist? Int J Radiat Oncol Biol Phys 46:805-814, 2000
29. Hojris I, Overgaard M, Christensen JJ, et al: Morbidity and mortality of ischaemic heart disease in high-risk breast cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: Analysis of DBCG 82b and 82c randomised trials. Radiotherapy Committee of the Danish Breast Cancer Cooperative Group. Lancet 354:1425-1430, 1999
30. Nixon AJ, Manola J, Gelman R, et al: No long-term increase in cardiac-related mortality after breast-conserving surgery and radiation therapy using modern techniques. J Clin Oncol 16:1374-1379, 1998
31. Rutqvist LE, Lax I, Fornander T, et al: Cardiovascular mortality in a randomised trial of adjuvant radiation therapy versus surgery alone in primary breast cancer. Int J Radiat Oncol Biol Phys 22:887-896, 1992
32. Paszat LF, Mackillop WJ, Groome PA, et al: Mortality from myocardial infarction after adjuvant radiotherapy for breast cancer in the Surveillance, Epidemiology, and End-Results cancer registries. J Clin Oncol 16:2625-2631, 1998